Concepedia

Lars Frison

LF

33

Publications

5K

Citations

25

H-Index

1992

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Sahlgrenska University Hospital

AstraZeneca (United Kingdom)

Birmingham City Hospital

Mount Sinai Medical Center

Lars Frison is an author at AstraZeneca (Sweden) specializing in medicine, pharmacotherapy, and pharmacology.

ORCID

Top concepts

Publications per year

1992–2021

33

Publications

33

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Gregory Y.H. Lip, Lars Frison, Jonathan L. Halperin et al. · Journal of the American College of Cardiology · 2010 · 1.1K citations

, , +15

Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

Gregory W. Albers, Hans‐Christoph Diener, Lars Frison et al. · JAMA · 2005 · 662 citations

Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design

Lars Frison, Stuart Pocock · Statistics in Medicine · 1992 · 602 citations

Identifying Patients at High Risk for Stroke Despite Anticoagulation

Gregory Y.H. Lip, Lars Frison, Jonathan L. Halperin et al. · Stroke · 2010 · 486 citations · Full text

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement

Giancarlo Agnelli, Alexander T. Cohen, Ola E. Dahl et al. · Thrombosis and Haemostasis · 2003 · 252 citations

Rows per page

1–5 of 33